Introduction to the NeuroNEXT Network for New Academic Investigators and Disease Study Groups

Notice Number: NOT-NS-12-019

Key Dates

Release Date: June 4, 2012

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)


The Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) is designed to increase the efficiency of clinical trials, to facilitate patient recruitment and retention, to increase the quality of neuroscience clinical trials, and to enable public-private partnerships. The network includes multiple Clinical Sites, one Clinical Coordinating Center (CCC), and one Data Coordinating Center (DCC); a listing of the sites and more information about the network may be found on the NeuroNEXT website ( This clinical research network will provide a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations.

This webinar is intended to introduce new Academic Investigators and existing Neurological Disease Study Groups to the NeuroNEXT network. We will give an overview of the network including its scope, purpose and available resources. Discussions on opportunities for disease study groups to apply and collaborate with NeuroNEXT will occur. The application process for NeuroNEXT will be explained. Time will be allotted for questions and answers.

Thursday, August 2, 2012 (1:00 PM 2:00 PM EST)

Teleconference number is toll-free: 1-877-739-5903

Access Code: 669-891-429

Audio PIN: Shown after joining the Webinar

Weblink: Reserve your Webinar seat now at

Title: Introduction to the NeuroNEXT Network for New Academic Investigators and Disease Study Groups

Date: Thursday. August 2, 2012

Time: 1:00 PM - 2:00 PM EST

After registering you will receive a confirmation email containing information about joining the Webinar.


Please direct all inquiries to:

D. Elizabeth McNeil, MD MSc
Telephone: 301-496-9135